Compare DENN & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DENN | MASS |
|---|---|---|
| Founded | 1953 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.8M | 324.4M |
| IPO Year | 1989 | 2020 |
| Metric | DENN | MASS |
|---|---|---|
| Price | $6.17 | $6.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $5.45 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 2.7M | 418.8K |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $457,212,000.00 | $65,045,000.00 |
| Revenue This Year | $6.56 | N/A |
| Revenue Next Year | $1.56 | $21.54 |
| P/E Ratio | $31.51 | ★ N/A |
| Revenue Growth | 0.93 | ★ 36.21 |
| 52 Week Low | $2.85 | $1.81 |
| 52 Week High | $7.66 | $9.34 |
| Indicator | DENN | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 65.68 | 48.47 |
| Support Level | $6.13 | $5.88 |
| Resistance Level | $6.20 | $6.64 |
| Average True Range (ATR) | 0.02 | 0.37 |
| MACD | -0.04 | 0.13 |
| Stochastic Oscillator | 64.29 | 86.27 |
Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.